Acutaas Chemicals Ltd.

•

acutaas.comBSE: 543349NSE: ACUTAAS

Market Cap₹ 26,194 Cr.

Current Price

High / Low₹ 3,740 / 1,302

Stock P/E65.9

Book Value₹ 213

Price to Book12.58

Dividend Yield0.08 %

ROCE32.9 %

ROE24.6 %

Face Value₹ 5

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has delivered good profit growth of 46.6% CAGR over last 5 years
Company is almost debt free
Company has a healthy return on capital (ROCE) of 21.0%
Latest quarter profit grew 70.0% YoY, showing strong momentum
Company has delivered good sales growth of 31.2% CAGR over last 5 years
Operating margins have improved to 36.5% from 20.6%

CONS

Promoter holding has decreased over last 2 years: -3.3pp
Free cash flow has been persistently negative
Total debt has risen sharply - up 278.8% year on year
Stock is trading at 12.6x its book value
Equity base is being diluted - shares outstanding up 12.3%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1904.00	37.77	456833.38	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9245.00	83.91	245425.70	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4924.70	85.89	187319.76	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1135.00	25.09	113216.68	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1389.00	33.29	112211.54	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1872.15	92.52	101154.55	0.11	3620.70	2139.42	20263.10	1191.00	18.20	31.50
7.	LUPIN	2135.00	17.66	97626.26	0.84	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	MANKIND	2345.00	47.42	96859.07	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
9.	DRREDDY	1155.00	29.92	96405.53	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	AUROPHARMA	1627.00	25.22	93613.98	0.25	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2458.80	38.60	69393.40	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	ACUTAAS	3199.45	67.82	26194.26	0.08	74.99	70.40	329.68	59.08	32.42	34.30

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	142	164	162	220	171	244	271	304	206	305	391	422	322
	117	145	138	180	145	195	204	220	155	209	237	241	223
Operating Profit	25	19	24	40	26	48	67	84	51	97	154	181	100
OPM %	17.82%	11.39%	14.55%	18.26%	15.37%	19.76%	24.60%	27.64%	24.76%	31.65%	39.45%	42.96%	30.87%
	1	-30	3	9	2	9	2	6	16	9	6	15	4
Interest	1	1	3	2	4	0	1	0	1	1	1	1	1
Depreciation	3	3	4	4	6	6	6	7	7	8	9	9	9
Profit before Tax	23	-16	20	42	18	50	63	83	59	97	151	186	104
Tax %	25.17%	-30.59%	22.81%	24.14%	24.67%	24.67%	27.57%	24.12%	24.23%	25.07%	25.97%	26.25%	27.03%
Net Profit	17	-21	16	32	14	38	45	63	45	73	112	137	76
	4.63	-5.75	4.29	4.37	1.71	4.70	5.66	7.84	5.45	8.90	13.63	16.74	9.27

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	160	188	236	240	341	520	617	688	990	1,324	1,440
	137	158	193	199	260	415	494	580	765	841	909
Operating Profit	23	31	43	41	80	105	123	108	225	483	532
OPM %	14.43%	16.23%	18.17%	17.14%	23.55%	20.22%	19.89%	15.66%	22.75%	36.49%	36.91%
	0	3	1	3	1	3	4	-18	18	46	34
Interest	3	3	5	6	6	6	2	6	6	3	4
Depreciation	1	2	3	4	4	10	12	15	24	33	35
Profit before Tax	19	28	37	35	72	91	112	69	214	493	538
Tax %	35.51%	34.82%	32.72%	20.96%	24.72%	21.33%	25.74%	36.79%	25.30%	25.69%	26.11%
Net Profit	12	18	25	27	54	72	83	44	160	366	397
EPS	80.33	122.93	23.46	8.72	17.14	21.03	22.87	11.85	19.49	44.73	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	15.19%	13.12%	25.33%	7.70%	5.59%	—

COMPOUNDED SALES GROWTH

10 Years:: 24%
5 Years:: 31%
3 Years:: 29%

COMPOUNDED PROFIT GROWTH

10 Years:: 40%
5 Years:: 47%
3 Years:: 64%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: 122%

RETURN ON EQUITY

10 Years:: 26%
5 Years:: 17%
3 Years:: 16%
Last Year:: 25%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2	2	10	10	32	36	36	37	41	41
	38	56	71	97	132	482	550	636	1,271	1,624
	23	41	48	54	117	1	3	172	11	32
Trade Payables	38	48	69	51	85	118	139	133	156	151
	8	9	14	15	44	18	30	93	60	87
Total Liabilities	109	155	212	228	410	655	759	1,071	1,538	1,935
	15	15	58	62	161	178	222	357	499	601
Capital Work in Progress	11	30	2	12	0	2	26	125	130	228
	15	21	28	28	33	33	33	68	68	118
	20	27	39	52	60	112	119	151	174	227
	0	0	0	0	0	0	0	213	289	360
Cash & Bank	3	1	0	3	2	99	59	32	241	165
	45	61	85	71	154	230	301	125	137	237
Total Assets	109	155	212	228	410	655	759	1,071	1,538	1,935

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	36	18	36	36	41	13	80	101	116	305
Cash from Investing	-19	-27	-25	-24	-101	-122	-20	-337	-234	-334
Cash from Financing	-7	14	3	0	72	140	-14	235	274	4
	2	-2	-0	3	-2	8	21	-1	155	-25

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	80.33	122.93	23.46	26.16	17.14	19.75	22.87	11.85	19.49	44.73
Book Value (₹)	262.32	385.69	77.25	102.84	52.05	142.16	161.04	182.43	160.19	203.40
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00	3.00	3.00	3.00	1.50	2.50
Cash EPS (₹)	2.13	3.23	4.32	4.92	3.08	11.26	13.13	7.91	11.21	48.76
PROFITABILITY
Operating Margin %	14.57%	17.76%	18.66%	18.30%	23.94%	20.75%	20.59%	15.66%	22.75%	36.49%
Net Margin %	7.52%	9.80%	10.46%	11.46%	15.85%	13.83%	13.51%	6.35%	16.12%	27.66%
ROE %	36.07%	37.94%	35.45%	29.06%	39.72%	21.10%	15.09%	6.94%	16.08%	24.60%
ROCE %	35.80%	37.76%	35.02%	26.68%	33.05%	23.88%	20.67%	10.22%	19.99%	32.94%
	12.03%	13.96%	13.41%	12.48%	16.92%	13.51%	11.79%	4.77%	12.23%	21.08%
EFFICIENCY
Debtor Days	83	84	95	95	92	98	116	118	93	90
Inventory Days	45	46	51	69	60	61	68	72	60	55
Payable Days	128	139	142	170	138	136	142	122	96	100
	-1	-10	4	-5	14	23	42	68	56	45
FINANCIAL HEALTH
Debt to Equity (x)	0.67x	0.75x	0.66x	0.55x	0.83x	0.00x	0.01x	0.30x	0.00x	0.01x
Interest Coverage (x)	6.67x	9.77x	8.70x	7.22x	13.77x	15.27x	47.49x	12.73x	37.46x	161.14x
	1.21x	1.33x	1.14x	1.23x	1.28x	3.30x	2.79x	1.75x	3.89x	3.62x
GROWTH
Revenue Growth %	4.27%	17.45%	25.17%	1.72%	42.13%	52.71%	18.57%	11.49%	43.96%	33.74%
Operating Profit Growth %	10.89%	43.16%	31.54%	-0.23%	85.90%	32.39%	17.64%	-4.36%	100.47%	117.22%
Net Profit Growth %	-4.76%	53.04%	33.58%	11.53%	96.57%	33.24%	15.84%	-47.58%	265.22%	129.51%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-48.21%	64.53%	129.50%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	46.19x	62.64x	57.20x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	6.00x	15.24x	12.58x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.27%	0.06%	0.10%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	34.64x	81.13x	39.34x

Shareholding Pattern

Numbers in percentages

Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
35.98	35.97	35.96	35.96	32.66	32.66	32.66	32.66	32.66
12.93	13.87	15.52	16.48	16.94	16.84	16.67	19.48	21.61
14.81	19.93	20.23	18.31	22.38	22.59	21.70	19.60	19.55
0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01
36.29	30.23	28.27	29.23	28.01	27.89	28.96	28.24	26.16

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04

General Updates

2026-09-04 - Acutaas Chemicals Limited has informed the Exchange about General Updates

2026-08-31

Copy of Newspaper Publication

2026-08-31 - Acutaas Chemicals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-29

General Updates

2026-08-29 - Acutaas Chemicals Limited has informed the Exchange about General Updates

2026-08-29

Record Date

2026-08-29 - Acutaas Chemicals Limited has informed the Exchange that Record date for the purpose of Dividend is 17-Sep-2026.

2026-08-29

Shareholders meeting

2026-08-29 - Acutaas Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026

2026-08-28

Press Release

2026-08-28 - Acutaas Chemicals Limited has informed the Exchange regarding a press release dated August 28, 2026, titled "Acutaas Chemicals step-down subsidiary Indichem inaugurates Semiconductor Materials Plant at Gongju, The Republic of Korea".

2026-08-24

Copy of Newspaper Publication

2026-08-24 - Acutaas Chemicals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-22

General Updates

2026-08-22 - Acutaas Chemicals Limited has informed the Exchange about General Updates

2026-08-18

General Updates

2026-08-18 - Acutaas Chemicals Limited has informed the Exchange about General Updates

News

Recent coverage and analyst commentary for ACUTAAS

Loading news…

🤖

AI Stock Analyst

Acutaas Chemicals Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account